Lykos to cut 75% of staff after FDA rejection of MDMA-based therapy
Lykos and its founder, Rick Doblin, have for years tried to persuade regulators and the pharmaceutical industry at large that psychedelic drugs should be used in the treatment of certain mental health conditions. “After 38 plus years of work, I’m profoundly saddened by the FDA decision around this critically needed therapy, but am heartened that…
Recent Comments